Recherche
-
COVID-19: France grapples with the pragmatics of isolation
(Lancet Public Health. vol. 5, n° 11, pp. E573-E574, 2020)Article de revueLibre accès -
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity
(Pharmacological Research. vol. 173, pp. 105848, 2021-11)Article de revueLibre accès -
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
(International Journal of Epidemiology. vol. 53, n° 1, 2024-02-01)Article de revueLibre accès -
Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study)
(Scientific Reports. vol. 13, n° 1, pp. 16535, 2023-10-02)Article de revueLibre accès -
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
(BMC Infectious Diseases. vol. 20, n° 1, pp. 850, 2020-11-16)Article de revueLibre accès -
One year of SARS-CoV-2 circulation in the Nouvelle-Aquitaine region, February 2021-2022, France
(Frontiers in Microbiology. vol. 14, pp. 1176575, 2023-07-28)Article de revueLibre accès -
Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?
(Malaria Journal. vol. 18, n° 1, pp. 123, 2019)Article de revueLibre accès -
Early complicated schistosomiasis in a returning traveler: key contribution of new molecular diagnostic methods
(International Journal of Infectious Diseases. vol. 79, pp. 72-74, 2019)Article de revueLibre accès -
Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease
(Journal of Translational Medicine. vol. 22, n° 1, pp. 246, 2024-03-07)Article de revueLibre accès -
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials
(CPT: Pharmacometrics and Systems Pharmacology, 2020)Article de revueLibre accès